| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | R$ 5.51B | R$ 4.94B | R$ 4.46B | R$ 3.99B | R$ 3.23B |
| Gross Profit | R$ 1.55B | R$ 1.57B | R$ 1.38B | R$ 1.24B | R$ 988.60M |
| Operating Income | R$ 238.29M | R$ 195.28M | R$ 166.57M | R$ 137.28M | R$ 102.95M |
| EBITDA | R$ 470.83M | R$ 427.65M | R$ 394.31M | R$ 333.02M | R$ 278.14M |
| Net Income | R$ 124.61M | R$ 105.51M | R$ 92.91M | R$ 86.34M | R$ 79.43M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | R$ 430.50M | R$ 213.41M | R$ 245.39M | R$ 157.35M | R$ 209.65M |
| Total Assets | R$ 3.83B | R$ 3.38B | R$ 3.08B | R$ 2.73B | R$ 2.38B |
| Total Debt | R$ 1.51B | R$ 1.24B | R$ 1.02B | R$ 871.54M | R$ 690.93M |
| Net Debt | R$ 1.46B | R$ 1.16B | R$ 994.73M | R$ 845.83M | R$ 636.49M |
| Total Liabilities | R$ 2.55B | R$ 2.14B | R$ 1.90B | R$ 1.62B | R$ 1.33B |
| Stockholders' Equity | R$ 1.28B | R$ 1.23B | R$ 1.17B | R$ 1.11B | R$ 1.05B |
| Cash Flow | |||||
| Free Cash Flow | R$ 299.14M | R$ 66.62M | R$ 157.18M | R$ 23.84M | R$ -4.40M |
| Operating Cash Flow | R$ 421.29M | R$ 224.45M | R$ 296.62M | R$ 205.48M | R$ 131.18M |
| Investing Cash Flow | R$ -383.35M | R$ -55.69M | R$ -196.56M | R$ -131.09M | R$ 14.90M |
| Financing Cash Flow | R$ -74.19M | R$ -116.71M | R$ -97.83M | R$ -103.11M | R$ -221.75M |
Dimed S.A. Distribuidora de Medicamentos (BR:PNVL3)
:PNVL3
